Stockreport

Kailera Therapeutics Announces Pricing of Initial Public Offering

 (KLRA) 
PDF WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on ele [Read more]